Hosoglu, S. et al. 2018. Use of carbapenems and glycopepdides is significant risk for multidrug resistant Acinetobacter baumannii infections. The Journal of Infection in Developing Countries. 12, 02 (Feb. 2018), 67–72. DOI:https://doi.org/10.3855/jidc.8081.